Literature DB >> 16645409

Slow coronary flow and stress myocardial perfusion imaging. Different patterns in acute patients.

Enrico Mangieri1, Gaetano Tanzilli, Giuseppe De Vincentis, Francesco Barillà, Silvia Remediani, Maria Cristina Acconcia, Cosimo Comito, Carlo Gaudio, Francesco Scopinaro, Paolo Emilio Puddu, Giuseppe Critelli.   

Abstract

OBJECTIVE: We investigated myocardial perfusion in acute patients with slow coronary flow (SCF) at angiography. Whether impaired myocardial perfusion occurs in acute patients with SCF is unknown.
METHODS: We enrolled 28 consecutive patients with SCF in the epicardial coronary arteries with no evidence of significant stenosis. SCF affected a single coronary artery in 14 patients (group A) and all three coronary vessels in 14 others (group B). Coronary angiography was repeated after dipyridamole infusion and single photon emission computed tomography was performed using dipyridamole as the stress agent. The Thrombolysis in Myocardial Infarction frame count was measured in SCF vessels at baseline and after dipyridamole infusion.
RESULTS: Mean Thrombolysis in Myocardial Infarction frame count significantly decreased after dipyridamole in both groups. At baseline, mean values of the single photon emission computed tomography score were 31.5 +/- 1.6 and 25.1 +/- 2.1 in groups A and B, respectively. After dipyridamole, they increased from 31.5 +/- 1.6 to 37.8 +/- 1.4 (P < 0.001) in group A, whereas a further decrease to 15.0 +/- 1.2 (P < 0.005) was observed in group B.
CONCLUSIONS: An opposite behavior of myocardial perfusion was observed after dipyridamole infusion: a normal response in patients with SCF affecting one single coronary artery versus an ischemic-like response in those with CSF affecting all three coronary arteries.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16645409     DOI: 10.2459/01.JCM.0000223253.16686.4d

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  6 in total

1.  Recurrence of Takotsubo cardiomyopathy with coronary slow flow phenomenon.

Authors:  Tomotake Tokunou; Kenji Sadamatsu
Journal:  J Cardiol Cases       Date:  2012-03-16

2.  Clinical analysis of the risk factors of slow coronary flow.

Authors:  Shuang Xia; Song-Bai Deng; Yang Wang; Jun Xiao; Jian-Lin Du; Yu Zhang; Xi-Chun Wang; Ye-Qing Li; Rui Zhao; Li He; Yu-Luan Xiang; Qiang She
Journal:  Heart Vessels       Date:  2011-01-05       Impact factor: 2.037

3.  Diverse spectrum of presentation of coronary slow flow phenomenon: a concise review of the literature.

Authors:  Muhammad A Chaudhry; Marcus Smith; Elias B Hanna; Ralph Lazzara
Journal:  Cardiol Res Pract       Date:  2012-05-08       Impact factor: 1.866

4.  A randomized, single-center double-blinded trial on the effects of diltiazem sustained-release capsules in patients with coronary slow flow phenomenon at 6-month follow-up.

Authors:  Lun Li; Ye Gu; Tao Liu; Yupeng Bai; Lingbo Hou; Zhong Cheng; Liqun Hu; Bo Gao
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

5.  Rosuvastatin was Effective in Acute Heart Failure and Slow Coronary Flow: A Hypothesis-generating Case Report.

Authors:  Alessio Arrivi; Gaetano Tanzilli; Paolo Emilio Puddu; Luca Iannucci; Enrico Mangieri
Journal:  Open Cardiovasc Med J       Date:  2013-01-31

Review 6.  The prognostic value of 123I-mIBG SPECT cardiac imaging in heart failure patients: a systematic review.

Authors:  Mariano Pontico; Gabriele Brunotti; Miriam Conte; Ferdinando Corica; Laura Cosma; Cristina De Angelis; Maria Silvia De Feo; Julia Lazri; Antonio Matto; Melissa Montebello; Arianna Di Rocco; Viviana Frantellizzi; Alessio Farcomeni; Giuseppe De Vincentis
Journal:  J Nucl Cardiol       Date:  2021-01-13       Impact factor: 3.872

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.